MX2020011741A - Método para controlar la evolución del hiperparatiroidismo mediante calcifediol, y composiciones para usarse en el mismo. - Google Patents
Método para controlar la evolución del hiperparatiroidismo mediante calcifediol, y composiciones para usarse en el mismo.Info
- Publication number
- MX2020011741A MX2020011741A MX2020011741A MX2020011741A MX2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A
- Authority
- MX
- Mexico
- Prior art keywords
- hyperparathyroidism
- compositions
- controlling
- calcifediol
- evolution
- Prior art date
Links
- 201000002980 Hyperparathyroidism Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 title 1
- 235000021318 Calcifediol Nutrition 0.000 title 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 title 1
- 229960004361 calcifediol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802148P | 2019-02-06 | 2019-02-06 | |
| PCT/IB2020/000089 WO2020161543A1 (en) | 2019-02-06 | 2020-02-06 | Method of controlling progression of hyperparathyroidism with calcifediol, and compositions for use therein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020011741A true MX2020011741A (es) | 2021-03-02 |
Family
ID=69903711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020011741A MX2020011741A (es) | 2019-02-06 | 2020-02-06 | Método para controlar la evolución del hiperparatiroidismo mediante calcifediol, y composiciones para usarse en el mismo. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220226351A1 (https=) |
| EP (1) | EP3920938A1 (https=) |
| JP (2) | JP2022519789A (https=) |
| KR (1) | KR20210126023A (https=) |
| CN (1) | CN113573714A (https=) |
| AU (2) | AU2020218639A1 (https=) |
| CA (1) | CA3128153A1 (https=) |
| MX (1) | MX2020011741A (https=) |
| WO (1) | WO2020161543A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2593047T3 (es) * | 2006-02-03 | 2016-12-05 | Opko Renal, Llc | Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3 |
| ES2670029T3 (es) | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D |
| KR20190028822A (ko) * | 2007-04-25 | 2019-03-19 | 사이토크로마 인코포레이티드 | 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
| HUE073014T2 (hu) | 2007-04-25 | 2025-12-28 | Opko Renal Llc | Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén |
| US11752158B2 (en) * | 2007-04-25 | 2023-09-12 | Eirgen Pharma Ltd. | Method of treating vitamin D insufficiency and deficiency |
| EP2281058B1 (en) | 2008-04-02 | 2016-06-29 | Opko Ireland Global Holdings, Ltd. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
| AU2013203489B2 (en) * | 2008-07-24 | 2015-02-05 | Wisconsin Alumni Research Foundation | Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration |
| WO2011123476A1 (en) * | 2010-03-29 | 2011-10-06 | Cytochroma Inc. | Methods and compositions for reducing parathyroid levels |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) * | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| JP7032322B2 (ja) | 2016-03-28 | 2022-03-08 | オプコ アイルランド グローバル ホールディングス リミテッド | ビタミンｄ治療法 |
| AU2019248829B2 (en) * | 2018-04-03 | 2025-02-06 | Opko Ireland Global Holdings, Ltd. | Use of calcifediol in bariatric surgery patients |
-
2020
- 2020-02-06 MX MX2020011741A patent/MX2020011741A/es unknown
- 2020-02-06 US US17/429,278 patent/US20220226351A1/en active Pending
- 2020-02-06 WO PCT/IB2020/000089 patent/WO2020161543A1/en not_active Ceased
- 2020-02-06 KR KR1020217026559A patent/KR20210126023A/ko not_active Ceased
- 2020-02-06 AU AU2020218639A patent/AU2020218639A1/en not_active Abandoned
- 2020-02-06 CA CA3128153A patent/CA3128153A1/en active Pending
- 2020-02-06 CN CN202080020844.6A patent/CN113573714A/zh active Pending
- 2020-02-06 JP JP2021569596A patent/JP2022519789A/ja active Pending
- 2020-02-06 EP EP20713085.7A patent/EP3920938A1/en active Pending
-
2024
- 2024-11-25 JP JP2024204631A patent/JP2025031720A/ja active Pending
-
2025
- 2025-10-30 AU AU2025259887A patent/AU2025259887A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210126023A (ko) | 2021-10-19 |
| JP2025031720A (ja) | 2025-03-07 |
| AU2020218639A1 (en) | 2021-08-12 |
| US20220226351A1 (en) | 2022-07-21 |
| JP2022519789A (ja) | 2022-03-24 |
| AU2025259887A1 (en) | 2025-11-20 |
| EP3920938A1 (en) | 2021-12-15 |
| WO2020161543A1 (en) | 2020-08-13 |
| CN113573714A (zh) | 2021-10-29 |
| CA3128153A1 (en) | 2020-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202102549B (en) | Substituted tolyl as fungicides | |
| CO2020016619A2 (es) | Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso | |
| LT3814348T (lt) | Pakeistieji naftiridinono junginiai, naudotini kaip t ląstelių aktyvatoriai | |
| MX2023007841A (es) | Metodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cancer. | |
| UY36730A (es) | Fenoxifenilamidinas sustituidas con halógeno y el uso de estas como fungicidas | |
| MX2019007030A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| CL2020000174S1 (es) | Automóvil. | |
| BR112018006696A2 (pt) | métodos e sistemas para obter óleo a partir de uma composição de vinhoto | |
| MX2019012352A (es) | Composiciones, sistemas, kits y metodos para ablacion neural. | |
| CY1124338T1 (el) | Αναστολεις 3-φωσφογλυκερικης αφυδρογονασης και χρησεις αυτων | |
| MX2020003605A (es) | Manipulación del metabolismo de triptamina. | |
| MX378235B (es) | Métodos para mejora hidráulica de cultivos. | |
| BR112019020338A8 (pt) | Composição para produção de tagatose, e, método de produção de tagatose | |
| MX2018000395A (es) | Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso. | |
| MX391750B (es) | Métodos para mejorar almenos una propiedad de un material, composiciones y usos relacionados con el mismo. | |
| EA201791233A1 (ru) | Материал стволовых клеток и способ его получения | |
| IL251616B (en) | Methods and compounds for the treatment and prevention of muscle mass loss | |
| BR112018009097A8 (pt) | spodoptera frugiperda resistente a vip3a | |
| BR112017020513A2 (pt) | método de produção de peixe para transplante, peixe para transplante, método de produção de espécie híbrida de peixe e espécie híbrida de peixe | |
| TR201903795T4 (tr) | Ngs si̇stemleri̇ kontrolü ve bunu kapsayan yöntemler | |
| EA201892368A1 (ru) | ИНГИБИТОРЫ ErbB И ИХ ПРИМЕНЕНИЕ | |
| MY176584A (en) | Gluconate repressor variant, microorganism containing the same producing l-lysine, and method for producing l-lysine | |
| MX390050B (es) | Composiciones para el cuidado personal | |
| MX2020007742A (es) | Procesos para preparar fluorocetolidos. | |
| MX2020004093A (es) | Puzolana de vidrio activada. |